TELA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.66 USD | +2.91% |
|
-1.39% | -14.50% |
| Jun. 04 | TELA Bio, Inc. Appoints Jeffrey Blizard to its Board of Directors | CI |
| May. 20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the 2021 Annual Meeting ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patientâs own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.71
USD
Average target price
14.2
USD
Spread / Average Target
+148.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.50% | 141M | |
| -6.03% | 180B | |
| +1.08% | 109B | |
| -2.19% | 68.93B | |
| -5.98% | 46.41B | |
| +12.31% | 45.43B | |
| +7.38% | 43.26B | |
| +15.98% | 30.05B | |
| +16.10% | 25.19B | |
| -6.79% | 23.34B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- Transcript : TELA Bio, Inc. - Shareholder/Analyst Call
